BK polyoma virus infection and renal disease in non-renal solid organ transplantation

Clinical Kidney Journal

Volumn 9, Issue 2, 2016, Pages 310-318

  Kuppachi, Sarat ^a   Kaur, Deepkamal ^a   Holanda, Danniele G ^a   Thomas, Christie P ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

BK polyoma virus; immunosuppression complication; interstitial nephritis; non renal solid organ transplantation

Indexed keywords

ANTIVIRUS AGENT; BRINCIDOFOVIR; CIDOFOVIR; CREATININE; LEFLUNOMIDE; MANITIMUS; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; TACROLIMUS; TERIFLUNOMIDE;

ACUTE GRAFT REJECTION; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; BK VIRUS INFECTION; BLOOD TRANSFUSION; CONTROLLED CLINICAL TRIAL (TOPIC); CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIFFERENTIAL DIAGNOSIS; ELECTRON MICROSCOPY; GRAFT RECIPIENT; HEALTH CARE QUALITY; HEART TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER GRAFT; MAINTENANCE DRUG DOSE; MULTICENTER STUDY (TOPIC); NON RENAL SOLID ORGAN TRANSPLANTATION; ORGAN TRANSPLANTATION; PAPANICOLAOU TEST; PHASE 2 CLINICAL TRIAL (TOPIC); PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEROPREVALENCE; TARGET ORGAN; URINE CYTOLOGY; VIROGENESIS; VIRUS LOAD;

EID: 84963936304     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfv143     Document Type: Review

References (88)

1. Gardner SD, Field AM, Coleman DV, et al. Newhuman papovavirus (B K) isolated from urine after renal transplantation. Lancet 1971; 1: 1253-1257
2. Padgett BL, Walker DL, ZuRhein GM, et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1: 1257-1260
3. DeCaprio JA, Garcea RL. A cornucopia of human polyomaviruses. Nat Rev Microbiol 2013; 11: 264-276
4. Nickeleit V, Singh HK. Polyomaviruses and disease: is there more to know than viremia and viruria?. Curr Opin Organ Transplant 2015; 20: 348-358
5. Goudsmit J, Wertheim-van Dillen P, van Strien A, et al. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol 1982; 10: 91-99
6. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973; 128: 784-787
7. Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71: 115-123
8. Knowles WA. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv Exp Med Biol 2006; 577: 19-45
9. Jiang M, Abend JR, Johnson SF, et al. The role of polyomaviruses in human disease. Virology 2009; 384: 266-273
10. Jin L, Gibson PE, Booth JC, et al. Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products. J Med Virol 1993; 41: 11-17
11. Sharma PM, Gupta G, Vats A, et al. Phylogenetic analysis of polyomavirus BK sequences. J Virol 2006; 80: 8869-8879
12. Boldorini R, Veggiani C, Barco D, et al. Kidney and urinary tract polyomavirus infection and distribution: molecular biology investigation of 10 consecutive autopsies. Arch Pathol Lab Med 2005; 129: 69-73
13. Behzad-Behbahani A, Klapper PE, Vallely PJ, et al. Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIVnon-infected) patients using polymerase chain reaction and microplate hybridisation. J Clin Virol 2004; 29: 224-229
14. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611-623
15. Chang D, Wang M, Ou WC, et al. Genotypes of human polyomaviruses in urine samples of pregnant women in Taiwan. J Med Virol 1996; 48: 95-101
16. Coleman DV, Gardner SD, Mulholland C, et al. Human polyomavirus in pregnancy. A model for the study of defence mechanisms to virus reactivation. Clin Exp Immunol 1983; 53: 289-296
17. Kahan AV, Coleman DV, Koss LG. Activation of human polyomavirus infection-detection by cytologic technics. Am J Clin Pathol 1980; 74: 326-332
18. Sundsfjord A, Flaegstad T, Flo R, et al. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 1994; 169: 485-490
19. Sundsfjord A, Osei A, Rosenqvist H, et al. BK and JC viruses in patients with systemic lupus erythematosus: prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J Infect Dis 1999; 180: 1-9
20. Jin L, Gibson PE, Knowles WA, et al. BK virus antigenic variants: sequence analysis within the capsid VP1 epitope. J Med Virol 1993; 39: 50-56
21. Heritage J, Chesters PM, McCance DJ. The persistence of papovavirus BK DNA sequences in normal human renal tissue. J Med Virol 1981; 8: 143-150
22. Shinohara T, Matsuda M, Cheng SH, et al. BK virus infection of the human urinary tract. J Med Virol 1993; 41: 301-305
23. Drachenberg CB, Papadimitriou JC, Wali R, et al. BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am J Transplant 2003; 3: 1383-1392
24. Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-Tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15: 324-332
25. Mackenzie EF, Poulding JM, Harrison PR, et al. Human polyoma virus (HPV)-A significant pathogen in renal transplantation. Proc Eur Dial Transplant Assoc 1978; 15: 352-360
26. Gardner SD, MacKenzie EF, Smith C, et al. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984; 37: 578-586
27. Hogan TF, Borden EC, McBain JA, et al. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 1980; 92: 373-378
28. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-Transplant recipients. N Engl J Med 2002; 347: 488-496
29. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-Allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309-1315
30. Ramos E, Drachenberg CB, Portocarrero M, et al. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002; 143-153
31. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145-2151
32. Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-Associated nephropathy. Kidney Int 2003; 64: 665-673
33. Doucette KE, Pang XL, Jackson K, et al. Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients. Transplantation 2008; 85: 1733-1736
34. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582-594
35. Vats A, Shapiro R, Singh Randhawa P, et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-Associated nephropathy in children and adults. Transplantation 2003; 75: 105-112
36. Randhawa P, Ho A, Shapiro R, et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 2004; 42: 1176-1180
37. Hariharan S. BK virus nephritis after renal transplantation. Kidney Int 2006; 69: 655-662
38. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirusassociated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277-1286
39. Singh HK, Andreoni KA, Madden V, et al. Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol 2009; 20: 416-427
40. Ding R, Medeiros M, Dadhania D, et al. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation 2002; 74: 987-994
41. Dadhania D, Snopkowski C, Ding R, et al. Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation 2010; 90: 189-197
42. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080-1089
43. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-Associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103-109
44. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant 2004; 4: 2082-2092
45. Amir A, Shapiro R, Shulman LM, et al. BK virus infection and its effect on renal function in pediatric liver-Transplant recipients: a cross-sectional, longitudinal, prospective study. Transplantation 2011; 92: 943-946
46. Brinkert F, Briem-Richter A, Ilchmann C, et al. Prevalence of polyomavirus viruria (JC virus/BK virus) in children following liver transplantation. Pediatr Transplant 2010; 14: 105-108
47. Loeches B, Valerio M, Perez M, et al. BK virus in liver transplant recipients: a prospective study. Transplant Proc 2009; 41: 1033-1037
48. Razonable RR, Brown RA, Humar A, et al. A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis 2005; 192: 1349-1354
49. Salama M, Boudville N, Speers D, et al. Decline in native kidney function in liver transplant recipients is not associated with BK virus infection. Liver Transpl 2008; 14: 1787-1792
50. Randhawa P, Uhrmacher J, Pasculle W, et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol 2005; 77: 238-243
51. Splendiani G, Cipriani S, Condo S, et al. Polyoma virus BK and renal dysfunction in a transplanted population. Transplant Proc 2004; 36: 713-715
52. Kusne S, Vilchez RA, Zanwar P, et al. Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance. J Infect Dis 2012; 206: 875-880
53. Barton TD, Blumberg EA, Doyle A, et al. A prospective crosssectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction. Transpl Infect Dis 2006; 8: 102-107
54. Loeches B, Valerio M, Palomo J, et al. BK virus in heart transplant recipients: a prospective study. J Heart Lung Transplant 2011; 30: 109-111
55. Pendse SS, Vadivel N, Ramos E, et al. BK viral reactivation in cardiac transplant patients: evidence for a double-hit hypothesis. J Heart Lung Transplant 2006; 25: 814-819
56. Thomas LD, Vilchez RA, White ZS, et al. A prospective longitudinal study of polyomavirus shedding in lung-Transplant recipients. J Infect Dis 2007; 195: 442-449
57. Thomas LD, Milstone AP, Vilchez RA, et al. Polyomavirus infection and its impact on renal function and long-Term outcomes after lung transplantation. Transplantation 2009; 88: 360-366
58. Schwarz A, Mengel M, Haller H, et al. Polyomavirusnephropathy in native kidneys after lung transplantation. Am J Transplant 2005; 5: 2582-2585
59. Egli A, Helmersen DS, Taub K, et al. Renal failure five years after lung transplantation due to polyomavirus BK-Associated nephropathy. Am J Transplant 2010; 10: 2324-2330
60. Menahem SA, McDougall KM, Thomson NM, et al. Nativekidney BK nephropathy post cardiac transplantation. Transplantation 2005; 79: 259-260
61. Schmid H, Burg M, Kretzler M, et al. BK virus associated nephropathy in native kidneys of a heart allograft recipient. Am J Transplant 2005; 5: 1562-1568
62. Haririan A, Ramos ER, Drachenberg CB, et al. Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient. Transplantation 2002; 73: 1350-1353
63. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940
64. Hirsch HH, Babel N, Comoli P, et al. European perspective on human polyomavirus infection, replication and disease in solid organ transplantation. Clin Microbiol Infect 2014; 20 (Suppl 7): 74-88
65. Sood P, Senanayake S, Sujeet K, et al. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. Transplantation 2012; 94: 814-821
66. Atencio IA, Shadan FF, Zhou XJ, et al. Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol 1993; 67: 1424-1432
67. Hardinger KL, Koch MJ, Bohl DJ, et al. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant 2010; 10: 407-415
68. Vasudev B, Hariharan S, Hussain SA, et al. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68: 1834-1839
69. Leung AY, Chan MT, Yuen KY, et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 528-537
70. Randhawa PS. Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis 2005; 41: 1366-1367; author reply 7
71. Portolani M, Pietrosemoli P, Cermelli C, et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res 1988; 9: 205-218
72. Gabardi S, Waikar SS, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol 2010; 5: 1298-1304
73. Knoll GA, Humar A, Fergusson D, et al. Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial. JAMA 2014; 312: 2106-2114
74. Lee BT, Gabardi S, Grafals M, et al. Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial. Clin J Am Soc Nephrol 2014; 9: 583-589
75. Waldman WJ, Knight DA, Blinder L, et al. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology 1999; 42: 412-418
76. Williams JW, Javaid B, Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005; 352: 1157-1158
77. Guasch A, Roy-Chaudhury P, Woodle ES, et al. Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. Transplantation 2010; 90: 891-897
78. Tohme FA, Kalil RS, Thomas CP. Conversion to a sirolimusbased regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients. Transpl Infect Dis 2015; 17: 66-72
79. Andrei G, Snoeck R, Vandeputte M, et al. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997; 41: 587-593
80. Kuypers DR, Vandooren AK, Lerut E, et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005; 5: 1997-2004
81. Kuten SA, Patel SJ, Knight RJ, et al. Observations on the use of cidofovir for BK virus infection in renal transplantation. Transpl Infect Dis 2014; 16: 975-983
82. Brody SR, Humphreys MH, Gambertoglio JG, et al. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Clin Pharmacol Ther 1999; 65: 21-28
83. Ortiz A, Justo P, Sanz A, et al. Tubular cell apoptosis and cidofovir-induced acute renal failure. Antivir Ther 2005; 10: 185-190
84. Lanier R, Trost L, Tippin T, et al. Development ofCMX001 for the treatment of Poxvirus infections. Viruses 2010; 2: 2740-2762
85. Reisman L, Habib S, McClure GB, et al. Treatment of BK virusassociated nephropathy with CMX001 after kidney transplantation in a young child. Pediatr Transplant 2014; 18: E227-E231
86. Randhawa PS, Schonder K, Shapiro R, et al. Polyomavirus BK neutralizing activity in human immunoglobulin preparations. Transplantation 2010; 89: 1462-1465
87. Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation 2006; 81: 117-120
88. Wadei HM, Rule AD, Lewin M, et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-Associated nephropathy (PVAN). Am J Transplant 2006; 6: 1025-1032